Analysis reveals that higher megakaryocyte repopulating ability correlates with lower MRD in Acute Myeloid Leukemia, suggesting implications for treatment strategies.
Key Points
Higher megakaryocyte repopulating ability is linked to lower measurable residual disease (MRD) in Acute Myeloid Leukemia patients.
Notably, 74% of maturing-like AML cases under 60 years achieved complete remission compared to 26% of HPC-like cases.
Assessment using multiparameter flow cytometry indicated megakaryocyte differentiation patterns correlated with MRD response.
Findings highlight the potential of megakaryopoiesis as a key predictor for MRD in younger patients with maturing-like AML subtypes.